# Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts

> **NCT03853785** · PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 45 (estimated)

## Conditions studied

- Condylomata Acuminata

## Interventions

- **BIOLOGICAL:** MMR vaccine
- **BIOLOGICAL:** Candida antigen
- **DRUG:** Topical Podophyllin

## Key facts

- **NCT ID:** NCT03853785
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02
- **Primary completion:** 2021-02
- **Final completion:** 2021-12
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2019-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03853785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03853785, "Efficacy of Intralesional MMR Vaccine,Intralesional Candidal Antigen&Topical Podophyllin in Treatment of Genital Warts". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03853785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*